Recommended Pages at researchandmarkets.com
Vaccines in the US - Market Research Reports - Research and Markets
researchandmarkets.com — “The market for vaccines in the US is all set to experience major growth in the coming years The ever rising demand for vaccines is predicted to account for over $15 billion by 2015 Almost 86% of the overall demand generated will be from human vaccines Both paediatric and adult vaccines will account...” View full resource at researchandmarkets.com
Most Recently Shared on August 2, 2011 at 1:37 pm By:
Vaccines to hit $15 billion by 2015. $PFE $GSK $MRK $NVS $SNY make up 80% of market. http://bit.ly/ob2Xlj via @lifesciencedata
Optimizing Treatment for Metastatic Clear Cell Renal Cell Carcinoma: US Oncologist Survey - Market Research Reports - Research and Markets
researchandmarkets.com — “Two patient specific case scenarios that unfold throughout the report, presented to 119 high-prescribing oncologists on Metastatic Clear Cell Renal Cell Cancer for their open responses on clinical decisions Patient progression reveals decisions in treatment throughout patient stages, factors...” View full resource at researchandmarkets.com
Most Recently Shared on April 14, 2011 at 2:48 pm By:
Kidney Cancer Health Executive
Report: Optimizing Treatment for Kidney Cancer http://bit.ly/gPBUkw
A Decision Support Tool for Optimizing the Melanoma Pipeline: From Research and Development to Market - Market Research Reports - Research and Markets
researchandmarkets.com — “This report comprises defined and up to date development strategies for 218 melanoma drugs within the portfolio of 138 companies, from Ceased to Marketed The report extensively analyses their 170 identified drug targets, organized into 151 drug target strategies, and assesses them in eight different...” View full resource at researchandmarkets.com
Most Recently Shared on November 29, 2010 at 7:14 pm By:
Melanoma Research Oncology, Dermatology, and Health Organization
New report comprises defined and up to date development strategies for 218 melanoma drugs within 138 companies. http://bit.ly/fwJGxU
Drug Patent Inventor Report 2010 - Market Research Reports - Research and Markets
researchandmarkets.com — “The Drug Patent Inventor Report profiles the individuals, US states, and countries leading pharmaceutical innovation Using data on drugs approved from 2000 to 2009, this report provides complete lists of: - Top Inventors Which inventors were granted the most patents? - Patents per Inventor The...” View full resource at researchandmarkets.com
Most Recently Shared on September 2, 2010 at 4:53 pm By:
Richard G. Lanzara Health Professional
RT @lifesciencedata Drug Patent Inventor Report 2010... http://bit.ly/b0Arnk -Interesting, I'm not in it. I must be out of the loop!
Updating Health Care Client Conflict-of-Interest Policies Regarding Doctors and Pharmaceutical Companies for 2010 - Market Research Reports - Research and Markets
researchandmarkets.com — “In Updating Health Care Client Conflict-of-Interest Policies Regarding Doctors and Pharmaceutical Companies for 2010, the webinar examines important changes that health care lawyers and their clients need to make to update their conflict-of-interest policies regarding doctors and pharmaceutical...” View full resource at researchandmarkets.com
Most Recently Shared on March 8, 2010 at 2:12 pm By:
RT @lifesciencedata UpdateHealth Care Client Conflict-of-Interest Policies Re Doctors and Pharma Cos for 2010 http://bit.ly/bCmKtL #hcsmeu
Roadmap for Success in Oncology - Market Research Reports - Research and Markets
researchandmarkets.com — “The worldwide oncology market is projected to outgrow the rest of the pharma industry, becoming the number one therapeutic class in revenue terms by 2011. So will oncology become pharma's new holy grail"? This Scrip analysis explains why the outlook is more complicated than that. Key topics covered: - Advances in cancer therapy post-launch of Roche/Genentech's Herceptin - Cancer drugs: an attractive marketplace; market forecasts, growth drivers - Managing a complex therapeutic area - Cancer drug” View full resource at researchandmarkets.com
Most Recently Shared on February 1, 2010 at 3:15 pm By:
Dr. P. D Tapp Doctor, Health Executive, and PhD
Roadmap for Success in Oncology: The worldwide oncology market is projected to outgrow the rest of the pharma indu... http://bit.ly/bnUcnR
US Neuropathic Pain 2008 - 4th Edition: Market Potential Through 2018 - Market Research Reports - Research and Markets
researchandmarkets.com — “This new EP Publications report: - Provides an epidemiological forecast for key conditions associated with neuropathic pain in the US market in 2008, 2013, and 2018 - Forecasts the potential value of the neuropathic pain market for ten indications through 2018 - Presents expert analysis of the...” View full resource at researchandmarkets.com
Most Recently Shared on December 2, 2008 at 9:24 pm By:
marcin chwistek Doctor, Internist, Pain Medicine Physician, and Physician
US Neuropathic Pain 2008 - 4th Edition: Market Potential Through 2018, including neuropathic cancer pain http://tinyurl.com/5m78ja
